IMI (LSE:IMI) fell 1.57% on Friday, as engineering and industrial shares eased in London while a sell-off in US technology dented risk appetite. No company-specific catalyst was identified for the session, and the decline is attributed to a broad weakening in cyclicals, not to news from the engineering group.

The broader market saw weakness in cyclicals amid the tech and artificial intelligence-led sell-off, with the Nasdaq down about 2.7% at the London close. IMI is a specialist engineering company that designs and makes precision flow-control and motion-control products used in industrial and other settings. Businesses of that kind rely on customers' Capital spending and the health of the industrial economy, so investors often treat them as cyclical. That description is general background and not a reported reason for the move.

The backdrop was dominated by Wall Street. The Nasdaq Composite closed at 25,437.00, down 747.73 points, or 2.86%, its biggest one-day percentage fall since June 5, and it ended October with its worst month since March 2025. The S&P 500 fell 1.82% to 7,580.07 and the Dow fell 1.09% to 51,770.31. It was Wall Street's worst day since June. Weak results from Intel and Amazon, released after Thursday's close, revived doubts that heavy AI spending will pay off, and Alphabet had fallen 12% on Thursday. Intel fell 28.6% and a chip index dropped 7.2%.

In London the effect was softer but still visible. The FTSE 100 closed up 7.71 points, or 0.07%, at 10,729.78, after drifting in and out of positive territory and ending well off its intraday highs. Large-cap defensives held the index up while the tech sell-off pushed it down. Consumer staples gained broadly, including Diageo (LSE:DGE), CCEP (LSE:CCEP), Unilever (LSE:ULVR), BAT (LSE:BATS), Reckitt (LSE:RKT), Sainsbury (LSE:SBRY) and Tesco (LSE:TSCO). Industrial peers fell alongside IMI, among them Weir Group (LSE:WEIR), Smiths Group (LSE:SMIN), Diploma (LSE:DPLM) and Halma (LSE:HLMA), with falls of between about 1.5% and 3%, which points to a sector-wide pattern.

The two parts of the market that moved against each other show the rotation. Investors favoured steady, consumer-oriented earners and sold businesses tied to the industrial cycle or to technology. The result was a flat index with a wide spread between winners and losers. AstraZeneca (LSE:AZN) jumped 7% on third-quarter results, and NatWest (LSE:NWG) fell about 8.8% after disappointing net interest Margin guidance.

Commodities added to the cautious tone. Miners fell as gold dropped about 2.8% and copper declined, and Brent Crude rose to about $117.61 a barrel.

Smaller companies were weaker as well. The FTSE 250 fell 0.9%, or 220.80 points, to 24,453.36, and the AIM All-Share fell 1.4%. Together with the cyclical weakness, this suggests investors were reducing exposure to economically sensitive and smaller-company shares and holding more of the large defensive names.

What can be concluded is modest. IMI (LSE:IMI) declined with its peers on a day when risk appetite faded, and nothing points to an announcement, trading statement, broker action or other event at the company. Any more detailed explanation would be guesswork.

For the month, the FTSE 100 rose just over 1%, its first monthly gain in three months, and it gained about 0.37% on the week. A small fall for an industrial engineer on a single Friday, in the context of a sharp global tech sell-off, is best treated as a market-driven move that tells us little about the Business itself.